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Abstract: Distinguishing ST-elevation myocardial infarction (STEMI) differential diagnoses is more challenging. Myoperi-
carditis is one of these differentials that results from viral involvement of myocardium and pericardium. My-
opericarditis in focal form can mimic electrocardiogram (ECG) features of acute STEMI and elevate cardiac en-
zymes. Myocarditis patients may face thrombolytic related complications such as intracranial bleeding, myocar-
dial rupture, and hemorrhagic cardiac tamponade. Furthermore, re-administration of streptokinase (a common
thrombolytic agent in our country) is banned for at least six months of previous administration; however, it can
save patients lives in emergency conditions such as massive pulmonary embolism. It seems that, when deal-
ing with a young patient presenting to emergency department with acute chest pain and ST segment elevation
on ECG, we should consider focal myocarditis as an important but rare differential diagnosis of STEMI. In this
report, we describe three cases of focal myocarditis, primarily misdiagnosed as STEMI.
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1. Introduction
Determining the necessity and timing of urgent revascu-
larization are important matters in patients who present
with chest pain accompanied by ST segment elevation and
possible myocardial infarction. Distinguishing differential
diagnoses of ST-elevation myocardial infarction (STEMI) is
even more challenging. Myopericarditis is one of these dif-
ferentials that results from viral involvement of myocardium
and pericardium of the heart. Pleuritic chest pain, fatigue
and decreased exercise capacity with history of a febrile syn-
drome are its common manifestations (1). Myopericarditis in
focal form can mimic acute STEMI in its electrocardiogram
(ECG) features and elevated cardiac enzymes (2). Endo-
myocardial biopsy (EMB) with the histological Dallas criteria
is the gold standard for diagnosing myocarditis. However,
when we have focal involvement, EMB is limited by high
variability and sampling error (3, 4). Recently, cardiac mag-
netic resonance (CMR) with gadolinium has been introduced
∗Corresponding Author: Masih Tajdini; Tehran Heart Center, Tehran Uni-
versity of Medical Sciences, Tehran, Iran. Tel: 00989125645406 / Fax:
00982188029731; Email: drmasih84@yahoo.com
as an accurate technique to differentiate acute myocarditis
from acute myocardial infarction (5, 6). Myocarditis pa-
tients may face thrombolytic related complications such
as intracranial bleeding, myocardial rupture, and hemor-
rhagic cardiac tamponade. Furthermore, re-administration
of streptokinase (a common thrombolytic agent in our
country) is banned for at least six months of previous admin-
istration; however, it can save patients lives in emergency
conditions such as massive pulmonary embolism, ischemic
stroke and STEMI (7, 8). In this report, we describe three
cases of focal myocarditis, primarily misdiagnosed as STEMI.
2. Case presentation
All three cases reported in this series are young patients pre-
sented to emergency department following 2-3 hours of con-
stant severe retrosternal chest pain and ECG findings in favor
of STEMI. Table 1 summarizes clinical and diagnostic find-
ings of patients and figure 1 shows 12 leads ECGs of cases.
All three patients were sent to catheterization laboratory and
were diagnosed with focal myocarditis, based on collective
evidence. Patients were treated with 600 mg Ibuprofen three
times a day along with 0.5 mg Colchicine twice daily for two
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Figure 1: 12-leads electrocardiogram of reported patients.
weeks. Abnormal ECG findings were reversed after three days
of treatment. Ejection fractions of patients at one-month
follow up echocardiography were 50-55%, 50%, and 50% for
cases 1 - 3, respectively. No evidence of regional wall motion
abnormality was detected on one-month follow up echocar-
diography of the studied patients. For all of these patients,
secondary causes of myopericarditis were assessed. All sero-
logic markers were in normal range.
3. Discussion
Chest pain accompanied by elevated cardiac enzymes
and normal coronary arteries are in favor of myocarditis
diagnosis. Although, our patients were young and had
history of preceding viral illness, ST- segment elevation,
which supports involvement of one vessel territory, raised
the possibility of an acute coronary syndrome. Myocardi-
tis is caused by diffuse inflammatory process of immune
system in response to an etiologic factor. The etiologic
factor is usually one of the following: infectious, post viral
autoimmune-related, autoimmune-mediated (lupus my-
ocarditis, giant-cell myocarditis [GCM]) or drug-associated
(hypersensitivity myocarditis, toxic myocarditis). Overlap
of virus-mediated damage, inflammation and autoimmune
dysregulation leads to myocardial injury and necrosis. Thus,
in generalized form of myocarditis, left ventricular dysfunc-
tion occurs and may proceed to end stage heart failure (9).
It seems that in focal myocarditis just a small section of
myocardium is involved, so there is less myocardial damage
and it is reversible.
Differential diagnosis
STEMI is the most important differential diagnosis of focal
myocarditis. Eosinophilic endomyocardial disease (Loeffler
syndrome) is another differential diagnosis that is character-
ized by extensive necrosis, mural and intravascular thrombi
without pathologic or clinical myocarditis. Hypersensitiv-
ity myocarditis is an important differential diagnosis that
should be ruled out, because cardiac function may improve
by cessation of offending drug. cardiac sarcoidosis (CS),
which is characterized by the presence of epithelioid gran-
ulomas formation, should also be considered in differential
diagnosis (10).
Emergency department management
Cardiac monitoring for detecting dysrhythmias is necessary
for these patients. Supplemental oxygen and fluid should
be considered based on the patient’s condition. Myocarditis
with reduced ejection fraction should be approached the
same as other causes of congestive heart failure (CHF).
Sympathomimetic drugs should be avoided due to their role
in increasing the extent of myocardial necrosis and mortality.
In addition, Beta-blockers should not be administered in
the acutely decompensated phase of illness. Temporary
pacemaker placement is required in symptomatic high de-
gree atrioventricular blocks but very few patients may need
permanent pacer or implantable cardioverter defibrillator
(ICD) placement (11).
Diagnostic approach
Definitive diagnosis can be confirmed by different tech-
niques. Endomyocardial biopsy is the gold standard method
with high specificity and low sensitivity. However, complica-
tions such as myocardial perforation and death have been
reported. In focal myocarditis, myocardial biopsy is not so
helpful because the involvement is local and biopsy may be
taken from the unaffected part (7, 8). Edema and myocyte
inflammation can be detected by cardiac magnetic reso-
nance imaging (MRI). Unlike MI, in which subendocardial
enhancement is the characteristic finding, in myocarditis
enhancement is originated from epicardium with suben-
docardial sparing. In a study, biopsy specimens taken from
areas of gadolinium enhancement had myocarditis features
on pathologic findings in 90% of cases (4, 5). In addition,
Cardiac computed tomography (CT) scan can be used for
diagnosis. Recent studies showed that findings were similar
between cardiac CT and MRI. Considering that CT has some
superiority in comparison to MRI, including feasibility of
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Table 1: Clinical and diagnostic findings of studied patients
Findings Case 1 Case 2 Case 3
Age (years) 41 20 26
Sex Male Male Female
Cardiac risk factor Cigarette smoker Negative Cigarette smoker
History of febrile disease URI 2 weeks ago URI 4 days ago Negative
Physical examination Normal Normal Normal
Vital signs
Systolic BP (mmHg) 110
Diastolic BP (mmHg) 70
Pulse rate / minute 90
Respiratory rate / minute 24
Temperature (C) 37
Electrocardiographic
ST elevation Π, IΠ, aVF I, aVL Π, IΠ, aVF
ST depression I, aVL IΠ, aVF aVL
Echocardiographic
Wall motion abnormality Base and mid-inferior Posterior No
Ejection fraction (%) 45 35-40 50
hs-cTnT (pg/ml)#
Baseline 450 83 177
3 hours later 711 1026 1395
Angiography Normal Normal Normal
*Normal range: < 14 pg/ml.
#hs-cTnT: high-sensitive cardiac troponin T.
URI:Upper respiratory tract infection.
coronary artery anatomy investigation, better evaluation of
myocardial inflammation and lower costs (11, 12). Speckle
tracking echocardiogram (STE) is a precise method for
evaluation of myocarditis patients. In a study, Strain (S) and
Strain Rate (SR) imaging were compared in acute myocardi-
tis patients with preserved left ventricular ejection fraction.
Septal thickness, left ventricular end-systolic dimension
(LVESD), and ejection fraction were different between them.
Therefore, this technique helps us thoroughly evaluate
patients who initially present with acute myocarditis (13).
In addition to cardiac injury markers, the level of brain
natriuretic peptide (BNP) can also be measured.
Prognosis
In contrast to generalized myocarditis that can proceed to
congestive heart failure and death due to arrhythmia or
severe left ventricular dysfunction, it seems that prognosis is
better in focal form (14-16). High concentrations of BNP are
correlated with poor prognosis in patients with myocarditis
(14).
4. Conclusion
When dealing with a young patient presenting to emergency
department with acute chest pain and ST segment elevation
on ECG, we should consider focal myocarditis as an impor-
tant but rare differential diagnosis of STEMI.
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